ARCHIVES

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Disappointed Over Response To Survey Leads; CRAG Proposals Inadequate, More Will Be Sought

August 6, 1976

Moves Forward With Approval From BSA

November 22, 2013

CMS Develops New Math of Medicare: Reimbursement Money for Outcomes Data.

February 4, 2005

Gloom and Doom Meeting of docs Turns Hopeful When Patient Offers Health Reform Proposal

February 5, 1993

CDC Offers Funds For 5-A-Day Program; CDC PA Available

May 14, 1999

Copeland Named Director, UF Cancer Center

February 10, 1995